Irinotecan in small-cell lung cancer.
Ando
Yuichi
Y
Figg
William D
WD
D000972:Antineoplastic Agents, Phytogenic / Q000008:administration & dosage* / Q000009:adverse effects; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D002166:Camptothecin / Q000008:administration & dosage* / Q000009:adverse effects / Q000031:analogs & derivatives*; D018288:Carcinoma, Small Cell / Q000188:drug therapy* / Q000235:genetics; D014453:Glucuronosyltransferase / Q000235:genetics*; D000077146:Irinotecan; D008175:Lung Neoplasms / Q000188:drug therapy* / Q000235:genetics; D011110:Polymorphism, Genetic; D011355:Prodrugs / Q000009:adverse effects
D000972:Antineoplastic Agents, Phytogenic; D011355:Prodrugs; D000077146:Irinotecan; D014453:Glucuronosyltransferase; D002166:Camptothecin